Upgrade to SI Premium - Free Trial

Vaxcyte, Inc. (PCVX) Misses Q2 EPS by 5c

August 6, 2025 6:22 PM

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($1.22), $0.05 worse than the analyst estimate of ($1.17).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

Categories

Earnings